Endoscopic Submucosal Dissection Market Report Scope & Overview:
The endoscopic submucosal dissection market size was valued at USD 370.47 million in 2024 and is expected to reach USD 568.31 million by 2032, growing at a CAGR of 5.51% over 2025-2032.
The endoscopic submucosal dissection market is on an upswing, supported by a 27% increase in global penetration of ESD procedures and the soaring prevalence of gastrointestinal cancers (26,890 new stomach cancer cases expected in the U.S. alone in 2024), stimulating both market demand and growth dynamics. Knives represent the highest product share, followed by gastroscopes and colonoscopes. Hospitals remain primary end-users.
Advances in technology, such as AI-enhanced imaging, hybrid knives, and HD systems, help streamline the procedure while ensuring patient safety, thereby driving the market expansion. There was a significant increase in R&D investments, including robotic-assisted navigation, precision instruments, and realistic simulation models (EndoGel) to promote training and adoption among clinicians. Regulatory approvals and clinician training projects continue to build supply availability, driving utilization as procedural barriers decrease. Endoscopic submucosal dissection (ESD) market growth and shares show positive correlation over time, accompanied by a rapid surge of disease incidence, and technological advancement and learning curves serving to drive preference for gentler organ-preserving minimally invasive treatment.
Market Dynamics:
Drivers:
-
Rising Clinical Adoption, Stronger Training, and Capital Inflows are Expanding Procedure Volumes and Device Innovation
Stronger clinical adoption has led to a continuous gain in procedure volumes, as more hospitals and specialty centers are adopting organ-preserving treatment for early gastrointestinal cancers, thus driving the endoscopic submucosal dissection market. As a result, ESD has become the standard treatment with which to treat early gastric cancer in most advanced healthcare systems and is performed more frequently than conventional surgery. The expansion of R&D capabilities by medical device manufacturers is spurring innovation in ESD knives, electrosurgical units, and precision accessories.
R&D is focusing on AI-assisted imaging, electrocautery-enhanced devices, and ergonomic endoscopes as it seeks to advance efficiency and safety. Swift regulatory approvals for new ESD devices are making market entry easier, increasing approval of products through hospitals and ambulatory surgical centers. Training improvements, including high-fidelity simulators and formal certification programs, are reducing the learning curve, allowing more clinicians to perform ESD safely. These two factors are fueling long-term growth of the market and will drive an increase in the global endoscopic submucosal dissection market size that has been analyzed.
Restraints:
-
Procedural Complexity, Workforce Constraints, and Reimbursement Ambiguity Limit Broader Diffusion
The endoscopic submucosal dissection market is growing, but it is facing several restraints. Anatomically, it is a complex procedure and a significant training time and experience is required to perform the same, which in turn causes a bottleneck of skilled operators. Few hospitals have a formalized practical ESD training course available for their staff, which means fewer individuals are being educated. Process times are lengthy in comparison to traditional endoscopic resections, which raises procedural cost and reduces throughput daily in the high-volume endoscopy unit.
Reimbursement policies are either vague or lacking in parts of the U.S., which deters providers (especially those at lower-volume centers) from providing ESD. Device introductions can be delayed by protracted regulatory evaluations or elaborate manufacturing procedures. However, the rapid technological advances are not there yet and require a deep clinical validation to become widely accepted. Taken together, these elements combine to slow the overall pace of ESD as companies must address the potential market while leaving a wide space between available technology and its adoption into the real clinical world.
Segmentation Analysis:
By Product
Gastroscopes & colonoscopes held over 35% market share in 2024, driven by vital presence in almost all ESD procedures, coupled with HD-imaging capabilities, narrow-band imaging, and higher maneuverability for accurate resections. Adoption was boosted by market leaders providing continuous upgrades and integration with AI-assisted detection tools. The area of Knives shows the highest growth, and innovations include water-jet integrated knives, insulated tip technology, and devices that facilitate cutting and coagulation simultaneously. These developments cut procedure times and bleeding risks, and fit with the modus operandi of endoscopists who are attracted to efficiency. Growing needs for specialized ESD knives in academic and commercial endoscopy centers, mainly due to the expansion of ESD training, are expected to drive the growth in these regions.
By Indication
Stomach cancer led a market share of more than 40% in 2024 and is anticipated to grow due to the high incidence rate of early gastric cancer levels in Japan, South Korea, and China (known for their national screening programs leading to an increased level of diagnosis with treatment through ESD). The fit-for-purpose nature of its early lesion complete block resection suggests long-term demand with attention to attracting new use cases for improved utilization.
However, the fastest-growing segment, colon cancer, is primarily driven by wider colorectal cancer screening initiatives in North America and Europe and increasing acceptance of ESD over EMR for large colorectal lesions. Improved training, more effective bowel preparation methods, and the evolution of colon-specific ESD tools are supporting growth globally.
By Technology
In 2024, conventional ESD was the leading technology with about half of the total share (around 55%), particularly in countries in which it is reimbursed and payment is not capped, driven by its clinical efficacy, ability for R0 resection, and high level of physician familiarity. Several manufacturers, extensive clinical literature, and many available compatible primes help maintain its dominance.
Hybrid ESD, the most rapidly escalating technique, utilizes a combination of submucosal dissection and snare resection, resulting in an improved technical learning curve and shorter procedural times. This approach has been attractive to adopters and EMR-defected endoscopy units as it reduces risks and the need for training, while maintaining acceptable resection results. Hybrid ESD is quite common in some of the emerging countries, and more people are getting trained in it as it can be cheaper and quicker to adopt compared to new device ideas.
By End-Use
Hospitals accounted for 60% of revenue share in 2024 as these are well-equipped, high patient pool, and have in-house interdisciplinary teams needed for complex ESD cases. The seamless integration of endoscopy suites with imaging and pathology departments for optimal treatment provision has helped in enhancing favoritism by patients and healthcare providers. Favorable trends for ASCs include shorter patient length of stay, lower costs, and growing reimbursement coverage for outpatient ESD. The shift to compact, high-definition endoscopic platforms and portable electrosurgical units is also allowing an ASC to perform complex resections with safety standards similar to those of hospital-based platforms. Patient demand for minimally invasive outpatient care with quicker recovery time also continues to drive their growth.
Regional Analysis:
North America dominated the market with a large inventory of minimally invasive procedures, well-developed healthcare infrastructure, and favorable reimbursement policies.
The U.S. endoscopic submucosal dissection market size was valued at USD 123.08 million in 2024 and is expected to reach USD 174.93 million by 2032, growing at a CAGR of 4.47% over 2025-2032. The U.S. constituted the major share with a huge patient base, early adoption of AI-assisted ESD systems, and well-established training programs. Government-led cancer screening programs are increasingly being implemented in Canada, which would boost the adoption at a stable rate. Advanced endoscopy centers with integrated imaging and pathology units perform thousands of ESD procedures each year in the U.S. North America also displays the highest growth, witnessed significantly in the U.S, while supported with ongoing R&D investment and FDA approvals for novel ESD Knives & Hybrid systems.
The Asia Pacific region held the largest share of the global market and is expected to remain dominant due to higher rates of gastric cancer incidence and improved detection trends. Japan is at the helm due to its national screening policy, the quality of endoscopists available, and the depth of clinical experience. The rapid growth that was seen in China reflects the large number of cancer cases, but also the local availability of cheap ESD equipment. India, on the other hand, is the fastest-growing country due to efforts made by government departments to develop healthcare infrastructure, along with increasing patient awareness and increasing private sector investment in endoscopic training facilities. The country also boasts significant penetration owing to its world-class hospitals and government-mandated reimbursement for gastric ESD.
Key Players:
Leading endoscopic submucosal dissection companies in the market include Medwork GmbH, EndoMed Systems GmbH, Taewoong Medical Co., Ltd., US Endoscopy, Apollo Endosurgery Inc., Endo Tools Therapeutics, HOYA Technosurgical, MTW Endoskopie Manufaktur W. Haag KG, Endoaccess GmbH, ASGE, M.I. Tech Co., Ltd., Medivators Inc. (Cantel Medical), EndoClot Plus Inc., Adeor Medical AG, LocaMed Ltd., Interscope Inc., Innovex Medical Co., Ltd., Nitinol Devices & Components Inc. (NDC), Ovesco’s OVESCO Clip Technology, and Microvasive Endoscopy.
Recent Developments:
In July 2024, Olympus Corporation launched its next-generation ESD Knife J with enhanced cutting precision and integrated water jet function, designed to improve procedure speed and safety, particularly for large colorectal lesions.
In March 2024, Boston Scientific received CE Mark approval for its Hybrid ESD System, enabling combined dissection and coagulation in a single device, aimed at reducing operation time and improving patient recovery outcomes in complex GI tumor cases.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 370.47 million |
| Market Size by 2032 | USD 568.31 million |
| CAGR | CAGR of 5.51% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Gastroscopes & Colonoscopes, Knives, Injection Agents, Tissue Retractors, Graspers & Clips, and Others) • By Indication (Stomach Cancer, Colon Cancer, Esophageal Cancer, and Others) • By End Use (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, and Others) • By Technology (Hybrid ESD, Conventional ESD, and Underwater ESD) |
| Regional Analysis/Coverage | North America (U.S., Canada), Europe (Germany, France, UK, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, Egypt, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America) |
| Company Profiles | LifeScan, Inc., Omron Healthcare, Inc., Medisana GmbH, Bionime Corporation, Beurer GmbH, Arkray, Inc., Trividia Health, Inc., SD Biosensor, Inc., Sinocare, Inc., Rossmax International Ltd., Andon Health Co., Ltd., ACON Laboratories, Inc., Ypsomed AG, Microlife Corporation, Medtronic plc, Ascensia Diabetes Care Holdings AG, Terumo Corporation, Intuity Medical, Inc., CareSens, and Nemaura Medical, Inc. |
Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Product
2.3.2 Market Size By Indication
2.3.3 Market Size By Technology
2.3.4 Market Size By End Use
2.4 Market Share & BPS Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Life Cycle Assessment
3.5 Parent Market Overview
3.6 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Reimbursement & Coverage Trends
4.1.1 Country-wise Payer Coverage Analysis
4.1.2 Cost-Effectiveness and Health Technology Assessment (HTA) Trends
4.2 R&D Investment and Funding Trends
4.2.1 Venture Capital and M&A Activity (2020–2024)
4.2.2 Public-Private and Regulatory-Backed Initiatives
4.3 Technology Integration Trends
4.3.1 AI-Enhanced Endoscopic Navigation & Imaging
4.3.2 Robotic-Assisted and Advanced Endoscopy Platforms
4.4 Clinical Trials and Pipeline Progression Metrics
4.4.1 ESD Device Development Trials by Product Category
4.4.2 Patient Enrollment & Procedure Access Challenges
4.5 Diagnostic and Treatment Penetration Rates
4.5.1 Early Cancer Detection and Screening Rates
4.5.2 ESD Procedure Volume & Utilization by Region
5. Endoscopic Submucosal Dissection Market Segmental Analysis & Forecast, By Product, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Gastroscopes & Colonoscopes
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Knives
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.4 Injection Agents
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
5.5 Tissue Retractors
5.5.1 Key Trends
5.5.2 Market Size & Forecast, 2021 – 2032
5.6 Graspers & Clips
5.6.1 Key Trends
5.6.2 Market Size & Forecast, 2021 – 2032
5.7 Others (electrosurgical units, overtubes, irrigation pumps, light sources, and related accessories)
5.7.1 Key Trends
5.7.2 Market Size & Forecast, 2021 – 2032
6. Endoscopic Submucosal Dissection Market Segmental Analysis & Forecast, By Indication, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Stomach Cancer
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Colon Cancer
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 Esophageal Cancer
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
6.5 Others (duodenal tumors, rectal tumors, and submucosal tumors in the GI tract)
6.5.1 Key Trends
6.5.2 Market Size & Forecast, 2021 – 2032
7. Endoscopic Submucosal Dissection Market Segmental Analysis & Forecast, By Technology, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 Hybrid ESD
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Conventional ESD
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Underwater ESD
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
8. Endoscopic Submucosal Dissection Market Segmental Analysis & Forecast, By End Use, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Hospitals
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Ambulatory Surgical Centers (ASCs)
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
8.4 Specialty Clinics
8.4.1 Key Trends
8.4.2 Market Size & Forecast, 2021 – 2032
8.5 Others (research & academic institutions, and training centers for endoscopic techniques)
8.5.1 Key Trends
8.5.2 Market Size & Forecast, 2021 – 2032
9. Endoscopic Submucosal Dissection Market Segmental Analysis & Forecast By Region, 2021 – 2032, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.2.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.2.4 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.2.5 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.2.6 Endoscopic Submucosal Dissection Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.2.6.1.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.2.6.1.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.2.6.1.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.2.6.2.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.2.6.2.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.2.6.2.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.3.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.3.4 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.3.5 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.3.6 Endoscopic Submucosal Dissection Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.3.6.1.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.1.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.1.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.3.6.2.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.2.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.2.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.3.6.3.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.3.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.3.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.3.6.4.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.4.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.4.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.3.6.5.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.5.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.5.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.3.6.6.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.6.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.6.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.3.6.7.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.7.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.7.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.3.6.8.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.3.6.8.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.8.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.4.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.4.4 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.4.5 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.4.6 Endoscopic Submucosal Dissection Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.4.6.1.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.4.6.1.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.1.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.4.6.2.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.4.6.2.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.2.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.4.6.3.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.4.6.3.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.3.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.4.6.4.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.4.6.4.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.4.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.4.6.5.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.4.6.5.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.5.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.4.6.6.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.4.6.6.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.6.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.4.6.7.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.4.6.7.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.7.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.5.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.5.4 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.5.5 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.5.6 Endoscopic Submucosal Dissection Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.5.6.1.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.5.6.1.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.1.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.5.6.2.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.5.6.2.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.2.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.5.6.3.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.5.6.3.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.3.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.5.6.4.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.5.6.4.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.4.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.5.6.5.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.5.6.5.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.5.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.6.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.6.4 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.6.5 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.6.6 Endoscopic Submucosal Dissection Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.6.6.1.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.6.6.1.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.1.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.6.6.2.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.6.6.2.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.2.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.6.6.3.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.6.6.3.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.3.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.6.6.4.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.6.6.4.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.4.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.6.6.5.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.6.6.5.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.5.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 Endoscopic Submucosal Dissection Market Size & Forecast, By Product, 2021 – 2032
9.6.6.6.2 Endoscopic Submucosal Dissection Market Size & Forecast, By Indication, 2021 – 2032
9.6.6.6.3 Endoscopic Submucosal Dissection Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.6.4 Endoscopic Submucosal Dissection Market Size & Forecast, By End Use, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number of Strategies Adopted by Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Medwork GmbH
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 EndoMed Systems GmbH
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 Taewoong Medical Co., Ltd.
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 US Endoscopy
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 Apollo Endosurgery Inc.
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 Endo Tools Therapeutics
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 HOYA Technosurgical
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 MTW Endoskopie Manufaktur W. Haag KG
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 Endoaccess GmbH
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 ASGE
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 Medivators Inc. (Cantel Medical)
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 EndoClot Plus Inc.
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 Adeor Medical AG
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 LocaMed Ltd.
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 Interscope Inc.
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 Innovex Medical Co., Ltd.
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 Nitinol Devices & Components Inc. (NDC)
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 Microvasive Endoscopy
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 M.I. Tech Co., Ltd.
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 Ovesco’s OVESCO Clip Technology
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Key Segments
By Product
- Gastroscopes & Colonoscopes
- Knives
- Injection Agents
- Tissue Retractors
- Graspers & Clips
- Others (electrosurgical units, overtubes, irrigation pumps, light sources, and related accessories)
By Indication
- Stomach Cancer
- Colon Cancer
- Esophageal Cancer
- Others (duodenal tumors, rectal tumors, and submucosal tumors in the GI tract)
By Technology
- Hybrid ESD
- Conventional ESD
- Underwater ESD
By End Use
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Specialty Clinics
- Others (research & academic institutions, and training centers for endoscopic techniques)
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- Egypt
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g., Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
Detailed analysis and profiling of additional market players
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
